Sector consensus Bio-Rad Laboratories, Inc. NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
01:40:00 21/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 365.08 USD | +8.33% |
|
+8.33% | +17.50% |
| 07/08 | RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating | MT |
| 05/08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 120.2 | +3.03% | 25 | |||||||
| 97.92 | +5.4% | 25 | |||||||
| 369.31 | +14.06% | 13 | |||||||
| 30,620 | +23% | 15 | |||||||
| 194.42 | +1.93% | 12 | |||||||
| 94.12 | +3.36% | 25 | |||||||
| 44.62 | +28.57% | 26 | |||||||
| 404.73 | +14.55% | 15 | |||||||
| 3,133.08 | +20.71% | 13 | |||||||
| 263.12 | +10.62% | 8 | |||||||
| 232.64 | +21.68% | 14 | |||||||
| 107.57 | +6.53% | 21 | |||||||
| 42.95 | -2.88% | 11 | |||||||
| 93.92 | +2.93% | 13 | |||||||
| 28.73 | +8.45% | 11 | |||||||
| 103.23 | +22.78% | 13 | |||||||
| 208.6 | +30.67% | 15 | |||||||
| 171.91 | +18.22% | 22 | |||||||
| 185.7 | +2.25% | 20 | |||||||
| Average | 1,921.93 | +12.41% | 17 | ||||||
| Weighted average by Cap. | 2,371.86 | +9.36% | 20 |
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
- Sector Bio-Rad Laboratories, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















